While sleep supplements can be beneficial, the lack of regulation means consumers are not assured of a safe and effective product.

In the United States, digestive diseases remain a significant cause of mortality, according to an analysis of multiple national databases.

In a recent clinical guideline, recommendations are presented for the diagnosis and management of eosinophilic esophagitis.

Donald Trump's administration has placed a freeze on information being released from government health agencies.

For young individuals with cancer, residence in redlined neighborhoods is associated with lower survival at five and 10 years.

A recent study finds that physiological metrics from wearable devices can help identify inflammatory bowel disease flares.

The majority of patients with postacute sequelae of COVID-19/post-COVID-19 syndrome do not recover in the second year of their illness.

The FDA has approved 2 additional vial sizes of Niktimvo™ (axatilimab-csfr), 9mg/0.18mL and 22mg/0.44mL, in addition to the 50mg/mL size.

The Trump administration has made some concessions to the halt placed on distributions of global HIV treatments via PEPFAR.

Private equity acquisition of US hospitals was associated with a significant worsening of patient-reported care experiences.

Patients with cryptogenic cirrhosis and definite celiac disease experienced significant clinical benefits when following a gluten-free diet.

Sociodemographic, health care, and clinical factors are associated with receipt of semaglutide in those with obesity but without diabetes.